Biopharmaceutical company Aptorum Group Ltd. (NASDAQ:APM) saw its pre-market stock price on Tuesday jump by nearly 300 percent, with investor optimism fueled by the company’s improved earnings ...
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results